Michael Craig Pine

Chief Corp Dev.&Strat. Officer, EyePoint Pharmaceuticals.

Companies

EyePoint PharmaceuticalsChief Corp Dev.&Strat. Officer Jan 14, 2022 to Jan 9, 2024¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jan 6, 2024Shares withheld for tax 5,966 shares at $20.40 of EyePoint Pharmaceuticals²
Jan 6, 2024Exercised options 15,285 shares of EyePoint Pharmaceuticals²
Dec 4, 2023Sold 1,000 shares at $20.79 of EyePoint Pharmaceuticals³
Dec 4, 2023Sold 45,000 shares at $22.00 of EyePoint Pharmaceuticals³
Dec 4, 2023Sold 45,000 shares at $22.00 of EyePoint Pharmaceuticals⁴
Dec 4, 2023Exercised options 45,000 shares at $12.62 of EyePoint Pharmaceuticals³
Dec 4, 2023Exercised options 45,000 shares at $12.62 of EyePoint Pharmaceuticals⁴
Mar 14, 2022Bought 1,000 shares at $12.21 of EyePoint Pharmaceuticals⁵

The numbers on this page point here. Each one links to the record it came from.